Advertisement
Singapore markets open in 2 hours 46 minutes
  • Straits Times Index

    3,264.53
    -35.51 (-1.08%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • Dow

    39,056.39
    +172.13 (+0.44%)
     
  • Nasdaq

    16,302.76
    -29.80 (-0.18%)
     
  • Bitcoin USD

    61,386.75
    -1,553.66 (-2.47%)
     
  • CMC Crypto 200

    1,307.04
    +12.37 (+0.96%)
     
  • FTSE 100

    8,354.05
    +40.38 (+0.49%)
     
  • Gold

    2,316.90
    -5.40 (-0.23%)
     
  • Crude Oil

    79.19
    +0.20 (+0.25%)
     
  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     
  • Nikkei

    38,202.37
    -632.73 (-1.63%)
     
  • Hang Seng

    18,313.86
    -165.51 (-0.90%)
     
  • FTSE Bursa Malaysia

    1,604.75
    -0.93 (-0.06%)
     
  • Jakarta Composite Index

    7,088.79
    -34.82 (-0.49%)
     
  • PSE Index

    6,659.18
    +40.60 (+0.61%)
     

Company News For Aug 6, 2019

  • Allergan plc’s AGN shares dipped 0.2% after the company reported second quarter 2019 earnings per share of $4.38, lower than $4.42 a share in the year ago quarter

  • Energizer Holdings, Inc.’s ENR shares lost 3.7% after the company reported third quarter fiscal 2019 earnings per share of $0.37, lower than the Zacks Consensus Estimate of $0.47

  • Shares of Edgewell Personal Care Company EPC lost 4.7% after the company reported third quarter fiscal 2019 revenues of $609 million, lower than the Zacks Consensus Estimate of $614 million

  • Shares of Mallinckrodt plc MNK fell 2.1% afterthe company reported second quarter 2019 revenues of $823 million, lower than the Zacks Consensus Estimate of $824 million


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Energizer Holdings, Inc. (ENR) : Free Stock Analysis Report
 
Edgewell Personal Care Company (EPC) : Free Stock Analysis Report
 
Allergan plc (AGN) : Free Stock Analysis Report
 
Mallinckrodt public limited company (MNK) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research